Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATP and Phosphocreatine with Fluoxetine in MDD
NCT03138681Phase 2Unknown
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- May 2017
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adenosine 5'-triphosphate, phosphocreatine in major depressive disorder (MDD), sponsored by Southern Medical University Zhujiang Hospital. Status: unknown.
02
Drugs
adenosine 5'-triphosphatephosphocreatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03138681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03138681.